搜索优化
English
全部
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
搜索
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
3 天
Canaccord下调Voyager Therapeutics目标价至$12,维持买入评级
周四,Canaccord Genuity维持对Voyager Therapeutics(NASDAQ:VYGR)的买入评级,但将其股票目标价从$14.00下调至$12.00。此次调整是基于公司2024年第四季度业绩以及最近关于其肌萎缩性侧索硬化症(ALS)基因疗法项目VY9323的公告。根据 InvestingPro ...
当前正在显示可能无法访问的结果。
隐藏无法访问的结果
今日热点
Trump signs funding bill
Israeli attack in Gaza
Chiefs sign Tillery
Kellogg's envoy role reduced
Syed formally resentenced
Gold rises to new heights
North Macedonia deadly fire
Child abuse images sentence
To review F-35 jets purchase
US expels SA ambassador
Survives 95 days at sea
Villanova fires head coach
Coffee creamer recall
Staff placed on leave
Wins longest-ever Iditarod
Electrical fire halts show
Withdraws nomination
Man wins $50M over burns
Felony gun possession arrest
US launches strikes in Yemen
Kupp signs with Seahawks
Texas measles outbreak
Laceration hazard recall
Second protester arrested
Deportation order blocked
RU, UKR launch attacks
Influencer leaves Australia
ISIS leader killed in Iraq
Pleads not guilty
Cuba suffers power outage
Severe weather outbreak
反馈